Compounds having Formula I
##STR1##
or pharmaceutically acceptable salts or prodrugs thereof, are useful for
treating pathological states which arise from or are exacerbated by
angiogenesis. The invention also relates to pharmaceutical compositions
comprising these compounds and to methods of inhibiting angiogenesis in a
mammal.
